ArticleBMC cancer2022

Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab.

J Guggenberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.